CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)

By Hancock G.E.   Heers K.M.   Smith J.D.   Scheuer C.A.   Ibraghimov A.R.   Pryharski K.S.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4874-4882

Elsevier

Access to resources Recommend Favorite

Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness

By Miller M.   Cho J.Y.   Baek K.J.   Castaneda D.   Nayar J.   Rodriguez M.   Roman M.   Raz E.   Broide D.H.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 3023-3033

Elsevier

Access to resources Recommend Favorite

Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge

By Mader D.   Huang Y.   Wang C.   Fraser R.   Issekutz A.C.   Stadnyk A.W.   Anderson R.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1110-1117

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation

By Jacquet A.   Haumont M.   Massaer M.   Garcia L.   Mazzu P.   Daminet V.   Gregoire D.   Jacobs P.   Bollen A.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1593-1602

Elsevier

Access to resources Recommend Favorite

Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

By Dale J.B.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 193-200

Elsevier

Access to resources Recommend Favorite